
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 23, 2000]
[Document not affected by Public Laws enacted between
  January 23, 2000 and December 4, 2001]
[CITE: 42USC285b-4]

 
                 TITLE 42--THE PUBLIC HEALTH AND WELFARE
 
                    CHAPTER 6A--PUBLIC HEALTH SERVICE
 
              SUBCHAPTER III--NATIONAL RESEARCH INSTITUTES
 
   Part C--Specific Provisions Respecting National Research Institutes
 
          subpart 2--national heart, lung, and blood institute
 
Sec. 285b-4. National research and demonstration centers


(a) Heart, blood vessel, lung, blood diseases, and blood resources; 
        utilization of centers for prevention programs

    (1) The Director of the Institute may provide, in accordance with 
subsection (c) of this section, for the development of--
        (A) ten centers for basic and clinical research into, training 
    in, and demonstration of, advanced diagnostic, prevention, and 
    treatment and rehabilitation methods (including methods of providing 
    emergency medical services) for heart and blood vessel diseases;
        (B) ten centers for basic and clinical research into, training 
    in, and demonstration of, advanced diagnostic, prevention, and 
    treatment and rehabilitation methods (including methods of providing 
    emergency medical services) for lung diseases (including bronchitis, 
    emphysema, asthma, cystic fibrosis, and other lung diseases of 
    children);
        (C) ten centers for basic and clinical research into, training 
    in, and demonstration of, advanced diagnostic, prevention, and 
    treatment methods (including methods of providing emergency medical 
    services) for blood diseases and research into blood, in the use of 
    blood products and in the management of blood resources; and
        (D) three centers for basic and clinical research into, training 
    in, and demonstration of, advanced diagnostic, prevention, and 
    treatment (including genetic studies, intrauterine environment 
    studies, postnatal studies, heart arrhythmias, and acquired heart 
    disease and preventive cardiology) for cardiovascular diseases in 
    children.

    (2) The centers developed under paragraph (1) shall, in addition to 
being utilized for research, training, and demonstrations, be utilized 
for the following prevention programs for cardiovascular, pulmonary, and 
blood diseases:
        (A) Programs to develop improved methods of detecting 
    individuals with a high risk of developing cardiovascular, 
    pulmonary, and blood diseases.
        (B) Programs to develop improved methods of intervention against 
    those factors which cause individuals to have a high risk of 
    developing such diseases.
        (C) Programs to develop health professions and allied health 
    professions personnel highly skilled in the prevention of such 
    diseases.
        (D) Programs to develop improved methods of providing emergency 
    medical services for persons with such diseases.
        (E) Programs of continuing education for health and allied 
    health professionals in the diagnosis, prevention, and treatment of 
    such diseases and the maintenance of health to reduce the incidence 
    of such diseases and information programs for the public respecting 
    the prevention and early diagnosis and treatment of such diseases 
    and the maintenance of health.

    (3) The research, training, and demonstration activities carried out 
through any such center may relate to any one or more of the diseases 
referred to in paragraph (1) of this subsection.

(b) Sickle cell anemia

    The Director of the Institute shall provide, in accordance with 
subsection (c) of this section, for the development of ten centers for 
basic and clinical research into the diagnosis, treatment, and control 
of sickle cell anemia.

(c) Cooperative agreements and grants for establishing and supporting; 
        uses for Federal payments; period of support, additional periods

    (1) The Director of the Institute may enter into cooperative 
agreements with and make grants to public or private nonprofit entities 
to pay all or part of the cost of planning, establishing, or 
strengthening, and providing basic operating support for centers for 
basic and clinical research into, training in, and demonstration of the 
management of blood resources and advanced diagnostic, prevention, and 
treatment methods for heart, blood vessel, lung, or blood diseases.
    (2) A cooperative agreement or grant under paragraph (1) shall be 
entered into in accordance with policies established by the Director of 
NIH and after consultation with the Institute's advisory council.
    (3) Federal payments made under a cooperative agreement or grant 
under paragraph (1) may be used for--
        (A) construction (notwithstanding any limitation under section 
    289e of this title);
        (B) staffing and other basic operating costs, including such 
    patient care costs as are required for research;
        (C) training, including training for allied health 
    professionals; and
        (D) demonstration purposes.

As used in this subsection, the term ``construction'' does not include 
the acquisition of land, and the term ``training'' does not include 
research training for which National Research Service Awards may be 
provided under section 288 of this title.
    (4) Support of a center under paragraph (1) may be for a period of 
not to exceed five years. Such period may be extended by the Director 
for additional periods of not more than five years each if the 
operations of such center have been reviewed by an appropriate technical 
and scientific peer review group established by the Director and if such 
group has recommended to the Director that such period should be 
extended.

(July 1, 1944, ch. 373, title IV, Sec. 422, as added Pub. L. 99-158, 
Sec. 2, Nov. 20, 1985, 99 Stat. 839; amended Pub. L. 100-607, title I, 
Sec. 128, Nov. 4, 1988, 102 Stat. 3055; Pub. L. 103-43, title V, 
Sec. 502, June 10, 1993, 107 Stat. 158.)


                               Amendments

    1993--Subsec. (a)(1)(D). Pub. L. 103-43 added subpar. (D).
    1988--Subsec. (a)(1)(A), (B). Pub. L. 100-607 inserted ``and 
rehabilitation'' after ``prevention, and treatment''.
